"Carcinoma, Papillary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
| Descriptor ID |
D002291
|
| MeSH Number(s) |
C04.557.470.200.360 C04.557.470.700.360
|
| Concept/Terms |
Carcinoma, Papillary- Carcinoma, Papillary
- Carcinomas, Papillary
- Papillary Carcinoma
- Papillary Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Papillary".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Papillary".
This graph shows the total number of publications written about "Carcinoma, Papillary" by people in this website by year, and whether "Carcinoma, Papillary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2006 | 3 | 0 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Papillary" by people in Profiles.
-
Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis. Pathol Res Pract. 2022 Dec; 240:154180.
-
Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review. Head Neck. 2022 01; 44(1):226-237.
-
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial. JAMA. 2018 05 08; 319(18):1880-1888.
-
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis. Tumour Biol. 2017 Oct; 39(10):1010428317713913.
-
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis. Clin Endocrinol (Oxf). 2017 Nov; 87(5):411-417.
-
Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol. 2017 Apr; 176(4):433-441.
-
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist. 2017 03; 22(3):255-263.
-
The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review. Oncotarget. 2017 Feb 07; 8(6):10637-10649.
-
Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries. Cancer Med. 2016 08; 5(8):1883-9.
-
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45.